Indivior Proposes New Corporate Structure to Achieve U.S. Domiciliation
Provided By PR Newswire
Last update: Oct 1, 2025
RICHMOND, Va., Oct. 1, 2025 /PRNewswire/ -- Indivior PLC (Nasdaq: INDV) ("Indivior PLC" or the "Company") today announced that it intends to pursue a change in domicile from the U.K. to the U.S. and will establish a new U.S. parent company, Indivior Pharmaceuticals, Inc. (IPI), above its existing U.K. parent company.
Read more at prnewswire.com
